| Literature DB >> 36107841 |
Reaz Mahmud1, K M Nazmul Islam Joy2, Mohammad Aftab Rassel3, Farhana Binte Monayem4, Ponkaj Kanti Datta5, Mohammad Sharif Hossain6, Mohammad Mahfuzul Hoque5, S M Habibur Rahman Habib7, Nazmul Hoque Munna8, Mohiuddin Ahmed1, S K Jakaria Been Sayeed3, Motlabur Rahman5, Ahmed Hossain Chowdhury1, Mohammad Zaid Hossain5, Kazi Gias Uddin Ahmed1, Md Titu Miah5, Md Mujibur Rahman9.
Abstract
BACKGROUND: Wearing masks or personal protective equipment (PPE) has become an integral part of the occupational life of physicians due to the coronavirus disease 2019 (COVID-19) pandemic. Most physicians have been developing various health hazards related to the use of different protective gears. This study aimed to determine the burden and spectrum of various health hazards associated with using masks or PPE and their associated risk factors.Entities:
Mesh:
Year: 2022 PMID: 36107841 PMCID: PMC9477277 DOI: 10.1371/journal.pone.0274169
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Patient selection for the cross-sectional survey.
Demography and distribution of different risk factors among the total population and the different subgroups.
| Characteristics | Total | Presence of at least 1 hazard, | p-value | Any type of dyspnea | p-value | Headache | p-value |
|---|---|---|---|---|---|---|---|
|
| 35.4 | 35.2 | 0.01 | 35.9 | 0.25 | 35.6 | 0.3 |
|
| 0.05 | 0.04 | 0.3 | ||||
|
| 437 | 425 | 171 | 329 | |||
|
| 69 | 64 | 36 | 48 | |||
|
| |||||||
| 351 | 339 | 0.9 | 148 | 0.38 | 245 | <0.001 | |
| 327 | 320 | 0.04, | 154 | <0.001, | 260 | 0.001 | |
|
| 0.001 | 0.007 | 0.3 | ||||
|
| 35 | 30 | 15 | 23 | |||
|
| 309 | 303 | 142 | 236 | |||
|
| 162 | 256 | 50 | 118 | |||
|
| 0.04 | 0.9 | 0.07 | ||||
|
| 377 | 367 | 155 | 284 | |||
|
| 73 | 71 | 30 | 58 | |||
|
| 56 | 51 | 22 | 35(62.5) | |||
|
| 0.8 | 0.003 | 0.6 | ||||
|
| 375(74.1) | 362 | 168 | 278 | |||
|
| 131 | 127 | 39 | 100 | |||
| 320 | 311 | 0.38, | 126 | 0.4 | 243 | 0.33, | |
|
| 0.34 | 0.03 | 0.43 | ||||
|
| 115 | 109 | 45 | 86 | |||
|
| 43 | 42 | 26 | 29 | |||
|
| 107 | 105 | 32 | 83 | |||
|
| 55 | 55 | 23 | 45 | |||
|
| 0.37 | 0.03 | 0.3 | ||||
|
| 187 | 184 | 90 | 146 | |||
|
| 35 | 34 | 14 | 26 | |||
|
| 4 | 4 | 0(0) | 4 | |||
|
| 0.04 | 0.01 | 0.03 | ||||
| 213 | 210 | 101 | 169 | ||||
|
| 293 | 279 | 106 | 268 | |||
|
| 0.8 | 0.025 | 0.27 | ||||
|
| 280 | 269 | 117 | 213(76) | |||
|
| 55 | 54(11) | 31 | 43(78.2) | |||
|
| 161 | 156(31.9) | 57 | 113(70.2) | |||
| 10 | 10 | 2 | 8(80) | ||||
|
| 272 | 267 | 0.04, | 132 | <0.001 | 205 | 0.6 |
|
| 0.7 | 0.001 | 0.6 | ||||
|
| 10 | 10 | 1 | 7 | |||
|
| 7 | 7 | 2 | 5 | |||
|
| 20 | 19 | 16 | 15 | |||
|
| 152 | 148 | 53 | 116 | |||
|
| 183 | 174 | 79 | 142 | |||
|
| 134 | 131 | 56 | 92 | |||
|
| 258 | 255 | 0.005 | 121 | 0.005, | 201 | 0.07 |
|
| |||||||
|
| 72 | 72 | 0.06, | 42 | 0.001 | 61 | 0.02, |
|
| 40 | 40 | 0.2, | 23 | 0.02, | 35 | 0.04, |
|
| 65 | 64 | 0.7, | 24 | 0.5 | 54 | 0.08 |
|
| 60 | 56 | 0.13, | 37 | <001 | 38 | 0.03 |
|
| 156 | 152 | 0.5 | 65 | 0.8 | 141 | 0.001 |
|
| 0.23 | 0.001 | 0.04 | ||||
|
| 90 | 84 | 38 | 75 | |||
|
| 280 | 273 | 131 | 207 | |||
|
| 119 | 115 | 35 | 86 | |||
|
| 17 | 17 | 3 | 9 | |||
a-A COVID-19-dedicated hospital or unit refers to hospital or a unit of a hospital designated by the government for the sole treatment of COVID-19-affected patients.
b-Role in clinical practice and duty pattern were described as per job description defined by directorate general of health, Bangladesh.
c-As described by the case definition of WHO.
d-As described by WHO and Bangladesh guidelines.
e-a mask along with other protective equipment for protection of the other parts of the body, which includes a coverall and/or face shield or goggles.
f-N-95 (3M) models like 8210, 1860.
g-3M full-face/half-face respirators.
h-Primary headache disorder was defined as headache, or a headache disorder, not caused by or attributed to another disorder, such as tension-type headache, migraine, and cluster headaches.
i-Evening clinical practice in own office after the regular duty in the public hospital.
j-Stress is the inability to cope with mental pressure and being overwhelmed with anxiety.
COVID-19: Corona virus disease 19.
PPE: Personal Protective Equipment.
Fig 2The spectrum of overall health hazards associated with using masks or PPE.
a. spectrum of severe health hazards related to using masks and or PPE b. spectrum of minor hazards related to using of masks and or PPE.
Severity (dyspnea and headache) and the functional impact of health hazards on the daily life of the physicians.
| Trait | Number | Percentage |
|---|---|---|
| Strenuous exercise | 27 | 24 |
| Walking uphill | 122 | 52 |
| Slowing down the pace | 28 | 12 |
| Stopping to walk | 11 | 5 |
| Breathless on routine exercise | 15 | 6 |
| Never | 58 | 15 |
| Rarely | 85 | 23 |
| Sometimes | 148 | 39 |
| Very often | 45 | 12 |
| Always | 41 | 11 |
|
| ||
| Never | 261 | 51.6 |
| Rarely | 66 | 13 |
| Sometimes | 142 | 28 |
| Very often | 33 | 6.5 |
| Always | 4 | 0.8 |
|
| ||
| Never | 322 | 63.6 |
| Rarely | 64 | 12.6 |
| Sometimes | 88 | 17.4 |
| Very often | 29 | 5.7 |
| Always | 3 | 0.6 |
|
| ||
| Never | 304 | 60 |
| Rarely | 67 | 13.2 |
| Sometimes | 104 | 20.5 |
| Very often | 29 | 5.7 |
| Always | 2 | 0.4 |
|
| ||
| Never | 315 | 62.2 |
| Rarely | 55 | 10.9 |
| Sometimes | 87 | 17.2 |
| Very often | 34 | 6.7 |
| Always | 15 | 3 |
|
| ||
| Never | 176 | 34.8 |
| Rarely | 92 | 18.2 |
| Sometimes | 142 | 28.1 |
| Very often | 56 | 11.1 |
| Always | 40 | 7.9 |
a. According to the MRC scale.
b. According to the verbal rating scale.
Risk factors of respiratory distress, headache, facial disfigurement, and excessive sweating.
|
|
|
|
|
|
|
|
|
|
| |||||||
| Working in COVID-19-dedicated units | Yes | 0.67 | 0.21 | 10.7 | 0.002 | 1.9 | 1.3–3 |
| Duty hours | <8 hour | -0.35 | 0.14 | 6.7 | 0.01 | 0.7 | 0.5–0.9 |
| Reuse of mask | Yes | 0.53 | 0.20 | 7.3 | 0.007 | 1.7 | 1.2–2.5 |
| Asthma | Yes | 0.74 | 0.28 | 7.01 | 0.008 | 2.1 | 1.2–3.6 |
| Diabetes | Yes | 0.73 | 0.36 | 4.2 | 0.04 | 2.1 | 1.0–4.2 |
| Obesity | Yes | 1.01 | 0.3 | 12.6 | 0.001 | 2.9 | 1.6–5.2 |
| Personal stress level | Low | -0.35 | 0.13 | 6.5 | 0.01 | 0.7 | 0.5–0.9 |
| Constant headache | -0.16 | 0.41 | 0.17 | 0.68 | 0.84 | ||
| Sex | Male | -0.91 | 0.26 | 12.04 | 0.001 | 0.4 | 0.24–0.67 |
| Working in COVID-19-dedicated units | Yes | 0.69 | 0.22 | 9.8 | 0.002 | 2.01 | 1.3–3.1 |
| Diabetes | Yes | 1.08 | 0.51 | 4.5 | 0.03 | 2.9 | 1.1–8.1 |
| Stress level | Low | -0.35 | 0.15 | 5.7 | 0.01 | 0.7 | 0.52–0.9 |
| Previous primary headache | Yes | 1.5 | 0.3 | 26.5 | <0.001 | 4.7 | 2.6–8.5 |
| Constant | 1.6 | 0.4 | 15.4 | <0.001 | 5.3 | ||
| Facial disfigurement | |||||||
| Sex | Male | -0.91 | 0.26 | 12.04 | 0.001 | 0.4 | 0.24–0.67 |
| Evening practice | No | -0.59 | 0.21 | 7.6 | 0.006 | 0.55 | 0.35–0.84 |
| Protection used | Mask only | -0.6 | 0.21 | 7.7 | 0.005 | 0.55 | 0.34–0.84 |
| Frequency of mask use | Daily | 0.56 | 0.24 | 5.7 | 0.02 | 1.8 | 1.1–2.8 |
| Reuse of mask | Yes | 0.58 | 0.2 | 6.9 | 0.02 | 1.8 | 1.2–2.8 |
| Duration of mask wearing | >6 hours | 0.27 | 0.11 | 6.01 | 0.014 | 1.3 | 1.1–1.6 |
| Constant | -2.6 | 0.8 | 11.2 | 0.001 | 0.07 | ||
| Excessive sweating | |||||||
| Age | -0.03 | 0.02 | 4.1 | 0.04 | 0.9 | 0.9–0.99 | |
| Sex | Male | -0.8 | 0.2 | 11.7 | 0.001 | 0.4 | 0.28–0.7 |
| Duty hours | <8 hour | -0.6 | 0.2 | 9.4 | 0.002 | 0.5 | 0.4–0.8 |
| Evening office practice | No | -1.5 | 0.4 | 14.8 | 0.001 | 0.21 | 0.09–0.5 |
| Practice duration | >4 hours | 0.4 | 0.14 | 9.9 | 0.002 | 1.5 | 1.2–2.1 |
| COVID-19 positivity | Positive | 0.6 | 0.16 | 13.1 | 0.001 | 1.8 | 1.3–2.5 |
| Protection used | Mask only | -1.7 | 0.26 | 41.8 | 0.001 | 0.18 | 0.11–0.3 |
| Mask Type | Non-Filtering | 0.30 | 0.14 | 4.8 | 0.03 | 1.3 | 1.1–1.8 |
| Hypertension | Yes | 0.89 | 0.33 | 7.4 | 0.007 | 2.4 | 1.2–4.6 |
| constant | 3.5 | 0.8 | 20.1 | 0.001 | 34.9 |
a. Analyzed with multivariate binary logistic regression; forward conditional methods were used.
b. Omnibus test of model coefficients, 0.000; Nagelkerke R, 19.9; Hosmer and Lemeshow test, 0.48; sensitivity, 67.8; conditional forward method; model at step 7.
c. Omnibus test of model coefficients, 0.000; Nagelkerke R, 18.8; Hosmer and Lemeshow test, 0.63; sensitivity, 75.2%; conditional forward method; model at step 5.
d. Omnibus test of model coefficients, 0.000, Nagelkerke R, 13.8; Hosmer and Lemeshow test, 0.82; sensitivity, 75.1%; conditional forward method; model at step 5.
e. Omnibus test of model coefficients, 0.000; Nagelkerke R, 32.1; Hosmer and Lemeshow test, 0.16; sensitivity, 78.1%; conditional forward method; model at step 9.
COVID-19: Corona virus disease 19.
OR: Odd ratio.
SE: Standard error.